Biomarker testing in non-small cell lung carcinoma – More is better: A case series
Biomarker testing in non-small cell lung carcinoma – More is better: A case series is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Biomarker testing in non-small cell lung carcinoma – More is better: A case series have?
Biomarker testing in non-small cell lung carcinoma – More is better: A case series has 15 citations in the OpenAlex counts ScholarIQ stores.
When was Biomarker testing in non-small cell lung carcinoma – More is better: A case series published?
Biomarker testing in non-small cell lung carcinoma – More is better: A case series has 2020 year in the ScholarIQ index.
What is the open-access status of Biomarker testing in non-small cell lung carcinoma – More is better: A case series?
Biomarker testing in non-small cell lung carcinoma – More is better: A case series has diamond oa status in the ScholarIQ index.
What is the DOI of Biomarker testing in non-small cell lung carcinoma – More is better: A case series?
The DOI for Biomarker testing in non-small cell lung carcinoma – More is better: A case series is on the source record.
What is the OpenAlex record for Biomarker testing in non-small cell lung carcinoma – More is better: A case series?
The OpenAlex for Biomarker testing in non-small cell lung carcinoma – More is better: A case series is on the source record.